Dorkenoo, Ameyo Monique http://orcid.org/0000-0002-1030-7757
Gbeasor-Komlanvi, Fifonsi Adjidossi http://orcid.org/0000-0002-1744-0454
Gbada, Komivi
Zida-Compaore, Wendpouiré Ida Carine http://orcid.org/0000-0001-5584-8111
Teou, Diwaba
Konu, Yao Rodion http://orcid.org/0000-0002-0506-0008
Lack, Fiali
Sadio, Arnold Junior http://orcid.org/0000-0001-5893-0663
Tchankoni, Martin Kouame http://orcid.org/0000-0001-9873-3293
Dagnra, Anoumou Claver http://orcid.org/0000-0003-3201-4063
Ekouevi, Didier Koumavi http://orcid.org/0000-0001-7644-9902
Funding for this research was provided by:
National Coordination for the Management of the Response to Covid-19
Faculty of Health Sciences of the University of Lomé
African Center of Research in Epidemiology and Public Health in Togo
Article History
Received: 16 August 2021
Accepted: 15 June 2022
First Online: 14 July 2022
Declarations
:
: The authors declare that they have no competing interests.
: Written informed consent was obtained from every adult enrolled and from the parent or guardian of each child enrolled in this study.
: All authors gave final approval for publication.
: The protocol for this study was approved by the Bioethics Committee for Health Research of the Togo Ministry of Health (No. 006/2020/CBRS). In addition, written informed consent was obtained from every adult enrolled and from the parent or guardian of each child enrolled in this study. Data collected are kept secured with a password and only the investigation team has access to this. No personal identification information has been reported. All patients tested positive by thick/thin blood smear or malaria RDT received artemether–lumefantrine fixed-dose combination tablets (Coartem<sup>®</sup>, Novartis Pharma, Switzerland) at no cost during 3 days in case of uncomplicated malaria according to Togo’s NMCP recommendations. However, treatment of severe malaria was at the patients’ charge. Patients tested positive for SARS-CoV-2 with PCR were notified to the surveillance division and referred to dedicated management centers in Lomé to benefit from the therapeutic protocol free of charge recommended in Togo.
Free to read: This content has been made available to all.